GERMANTOWN, Wis.--(BUSINESS WIRE)--Cambridge Major Laboratories today announced a major expansion into large scale Active Pharmaceutical Ingredient (API) manufacturing. On June 5, 2008 the company will be breaking ground on a new 120,000 square foot, state-of-the-art API manufacturing site next to its headquarters in Germantown, Wisconsin USA. The facility is designed with multiple GMP manufacturing suites capable of producing multi-ton quantities of API, and is in response to the company’s large and growing pipeline of late developmental and commercial API’s. Completion is scheduled for August of 2009.
